Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Intercept Pharmaceuticals, London, UK.
Liver Int. 2022 May;42(5):984-994. doi: 10.1111/liv.15209. Epub 2022 Mar 7.
BACKGROUND & AIMS: Though lifestyle interventions can reverse disease progression in people with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH), unawareness about disease severity might compromise behavioural changes. Data from this first international cross-sectional survey of individuals with NAFLD/NASH were used to identify correlates of both unawareness about fibrosis stage and its association with adherence to lifestyle adjustments.
Adults with NAFLD/NASH registered on the platform Carenity were invited to participate in an online 20-min, six-section survey in Canada, France, Germany, Italy, Spain and the United Kingdom to describe their experience with NAFLD/NASH and its care (N = 1411). Weighted binary and multinomial logistic regressions were performed to estimate the effect of explanatory variables on unawareness of fibrosis stage and poor adherence to lifestyle changes respectively.
In the study group, 15.5% had obesity and 59.2% did not know their fibrosis stage. After multiple adjustments, individuals with a body mass index (BMI) ≥35 were over twice as likely to not know their fibrosis stage. People with a BMI >30 had a threefold higher risk of having poor adherence to lifestyle changes. Unawareness about fibrosis stage was also significantly associated with poor adherence to lifestyle adjustments.
As fibrosis stage is becoming the main predictor of NAFLD progression, improving patient-provider communication-especially for people with obesity-about liver fibrosis stage, its associated risks and how to mitigate them, is needed. Training for healthcare professionals and promoting patient educational programmes to support behaviour changes should also be included in the liver health agenda.
尽管生活方式干预可以逆转非酒精性脂肪性肝病/非酒精性脂肪性肝炎(NAFLD/NASH)患者的疾病进展,但对疾病严重程度的认识不足可能会影响行为改变。本研究首次对 NAFLD/NASH 患者进行了国际横断面调查,利用这些数据来确定对纤维化分期认识不足的相关因素及其与生活方式调整依从性的关系。
在 Carenity 平台上注册的 NAFLD/NASH 患者被邀请参加一项在线 20 分钟的六部分调查,以描述他们的 NAFLD/NASH 体验及其护理情况(N=1411)。采用加权二项和多项逻辑回归来估计解释变量对纤维化分期认识不足和生活方式改变依从性差的影响。
在研究组中,15.5%的患者肥胖,59.2%的患者不知道自己的纤维化分期。经过多次调整后,BMI≥35 的个体不知道自己纤维化分期的可能性是 BMI<35 的个体的两倍多。BMI>30 的个体发生生活方式改变依从性差的风险增加了三倍。对纤维化分期的认识不足也与生活方式调整的依从性差显著相关。
由于纤维化分期正在成为 NAFLD 进展的主要预测因素,因此需要改善医患沟通,特别是针对肥胖患者,向他们说明肝纤维化分期、相关风险以及如何减轻这些风险。还应将医疗保健专业人员的培训和促进患者教育计划纳入肝脏健康议程,以支持行为改变。